Page last updated: 2024-10-30

leflunomide and Forestier-Certonciny Syndrome

leflunomide has been researched along with Forestier-Certonciny Syndrome in 3 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Research Excerpts

ExcerptRelevanceReference
"A man (age: 76 years) on prednisone and leflunomide for polymyalgia rheumatica developed spontaneous severe haematomas."3.76[Rituximab in the treatment of acquired haemophilia A in a patient with polymyalgia rheumatica]. ( Braunert, L; Bruegel, M; Niederwieser, D; Pfrepper, C; Thiery, J, 2010)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Diamantopoulos, AP1
Hetland, H1
Myklebust, G1
Braunert, L1
Bruegel, M1
Pfrepper, C1
Thiery, J1
Niederwieser, D1
Adizie, T1
Christidis, D1
Dharmapaliah, C1
Borg, F1
Dasgupta, B1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Multicenter Randomized Placebo Controlled Treatment Study of Leflunomide in Polymyalgia Rheumatica[NCT03576794]Phase 394 participants (Anticipated)Interventional2019-03-01Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

3 other studies available for leflunomide and Forestier-Certonciny Syndrome

ArticleYear
Leflunomide as a corticosteroid-sparing agent in giant cell arteritis and polymyalgia rheumatica: a case series.
    BioMed research international, 2013, Volume: 2013

    Topics: Adrenal Cortex Hormones; Aged; Female; Giant Cell Arteritis; Giant Cells; Humans; Isoxazoles; Leflun

2013
[Rituximab in the treatment of acquired haemophilia A in a patient with polymyalgia rheumatica].
    Hamostaseologie, 2010, Volume: 30 Suppl 1

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Murine-Derived; Cyclophospham

2010
Efficacy and tolerability of leflunomide in difficult-to-treat polymyalgia rheumatica and giant cell arteritis: a case series.
    International journal of clinical practice, 2012, Volume: 66, Issue:9

    Topics: Aged; Aged, 80 and over; Antirheumatic Agents; Case-Control Studies; Female; Giant Cell Arteritis; H

2012